- Home
- EVTC vs IMVT Comparison
EVTC vs IMVT Comparison
Compare EVTC & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTC
- IMVT
- Stock Information
- Founded
- EVTC 1988
- IMVT N/A
- Country
- EVTC United States
- IMVT United States
- Employees
- EVTC N/A
- IMVT N/A
- Industry
- EVTC EDP Services
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVTC Technology
- IMVT Health Care
- Exchange
- EVTC Nasdaq
- IMVT Nasdaq
- Market Cap
- EVTC 2.0B
- IMVT 2.5B
- IPO Year
- EVTC 2013
- IMVT N/A
- Fundamental
- Price
- EVTC $36.19
- IMVT $14.85
- Analyst Decision
- EVTC Buy
- IMVT Buy
- Analyst Count
- EVTC 4
- IMVT 10
- Target Price
- EVTC $40.00
- IMVT $40.14
- AVG Volume (30 Days)
- EVTC 329.9K
- IMVT 1.2M
- Earning Date
- EVTC 05-07-2025
- IMVT 05-29-2025
- Dividend Yield
- EVTC 0.55%
- IMVT N/A
- EPS Growth
- EVTC 101.39
- IMVT N/A
- EPS
- EVTC 2.00
- IMVT N/A
- Revenue
- EVTC $868,960,000.00
- IMVT N/A
- Revenue This Year
- EVTC $7.97
- IMVT $108.88
- Revenue Next Year
- EVTC $4.98
- IMVT N/A
- P/E Ratio
- EVTC $18.16
- IMVT N/A
- Revenue Growth
- EVTC 17.39
- IMVT N/A
- 52 Week Low
- EVTC $28.76
- IMVT $12.72
- 52 Week High
- EVTC $38.56
- IMVT $34.47
- Technical
- Relative Strength Index (RSI)
- EVTC 51.37
- IMVT 50.48
- Support Level
- EVTC $36.29
- IMVT $13.79
- Resistance Level
- EVTC $36.91
- IMVT $15.22
- Average True Range (ATR)
- EVTC 0.61
- IMVT 0.69
- MACD
- EVTC -0.14
- IMVT 0.13
- Stochastic Oscillator
- EVTC 11.24
- IMVT 78.24
About EVTC Evertec Inc.
Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions which derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely.
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).